11
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Om behandling med carbamazepin (Tegretol) av orotillstånd uppträdande i samband med svåra fall av hjärnskador och utvecklingsrubbningar

, &
Pages 44-52 | Published online: 12 Jul 2009

References

  • Blom S. Tic douloureux treated with new anticonvulsant: experiences with G 32883. Arch. Neurol. 1963; 9: 285–290
  • Braunhofer J., Jesch W. Klinische Erfahrungen mit einem neuen Dibenzazepinderivat (G 32883) in der Behandlung Trigeminusneuralgie. Med. Welt 1964; 26: 200–203
  • Dahlerup J. Behandling af idiopatisk trigeminusneuralgi med forsogspreparat G 32883 (Tegretol). Ugeskr. Læg. 1965; 127: 1024–1023
  • Donner M., Frisk M. Carbamazepine treatment of epileptic and psychic symptoms in children and adolescents. Ann. Paediat. Fenn. 1965; 11: 91–97
  • Gaylor J. Advances in Neurology. Practitioner 1964; 193: 453–460
  • Güntelberg E. Epilepsiebehandling med et nyt framkon, G 32883. Ugeskr. Læg. 1964; 126: 1326–1329
  • Jongmans J. W. M. Report on the Anti-Epileptic Action of Tegretol. Epilepsia 1964; 5: 74–82
  • Ketz E. Tegretol – ein neues Antiepileptikum. Praxis 1964; 53: 264–269
  • Largé M. Klinische Erfahrungen mit einem neuen Antiepileptikum, Tegretol (G 32883) mit besonderer Wirkung auf die epileptische Wesensveränderung. Schweiz. Med. Wschr. 1963; 93: 1042–1047
  • Pakesch E. Untersuchungen über ein neuartiges Antiepileptikum. Wien. Med. Wschr. 1963; 113: 794–796
  • Spillane J. D. The treatment of trigeminal neuralgia: preliminary experience with Tegretol. Practitioner 1964; 192: 71–77
  • van Steenbrugghe A. Utilisation d'un derive de l'iminostilbene. Ars. Med. 1965; 20: 380–382
  • Warot P., Petit H., Delandtscheer J. M., Arnott G., Fourlinnie J. C. Une aquisition importante dans le traitement de la névralgie faciale: le G. 32883 (Tégrétol). Lille Medical 1964; 3: 769–778

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.